Site hosted by Angelfire.com: Build your free website today!

Compassionate Medical Technologies Announces FDA Approval of New Tamper-Resistant Drug Delivery System

 

Altoona, PA (AP Newswire) November 16, 2005. For immediate release.


Compassionate Medical Technologies (NASDAQ: NITRO) announced today that it has obtained FDA approval for its new patented medication anti-tampering technology. The product, Bloemof-ER, is an extended-release matrix that slowly releases medication over a 48-hour period.

Previous products have used time-release matrices but drug abusers quickly learned to defeat the time-release function and obtain immediate release. The most notorious of these drugs, OxyContin, has been dubbed "Hillbilly Heroin" for its extremely addictive nature. OxyContin can be crushed and snorted or injected to release 12 hours' worth of medication immediately, producing an intense "high". According to Michael Gordon of the National Association for the Fluoridation of Bourbon the manufacturer of OxyContin, Purdue Frederick, has been trying to devise a tamper-proof product for several years without success. Gordon notes that a similar product, Palladone, was withdrawn from the market earlier this year after it was shown that a 5 year old child could dissolve the matrix with just a teaspoon of warm milk. “You really have to wonder what color the sky is on their world,” says Gordon, “These guys are clueless.”

"We felt that since we were packing 2 entire days worth of medicine in these puppies that we'd better make sure people would think twice about trying to adulterate them," said CMT CEO Arthur Jackson. Jackson then went on to explain that adulteration has nothing to do with sex but is actually a term referring to changing the nature of the pill to defeat its intended use. Jackson continued, "We decided there should be consequences for deviant actions, and that those consequences, like the consequences of all criminal behavior, should be swift and sure."

"We decided to make it explode if it was crushed," concluded Jackson.

"Our studies have shown that the resulting explosion would completely remove (if chewed) at least three molars and 4.3 grams of the mandible. However, this would not be a deterrent in certain states such as West Virginia, where a complete set of teeth is not only rare, but considered abnormal. It is also capable of removing 1.8 fingers, on average. We think that is a pretty good deterrent. You may not have teeth, but you probably still want to pick your nose."

 


Early studies in Federal prisoners showed high efficacy in deterring adulteration attempts. Although the formulation does not stop the first attempt, further attempts by the perpetrator and associates are strongly deterred.


The FDA has required a "black box" warning for the product indicating that smoking is not permitted within 6 feet of the medication. Pharmacies stocking the drug would be required to have appropriate federal permits from ATF for the handling and sale of explosives. Dr. Jackson was somewhat reluctant to discuss some of the company's early clinical trials involving depleted uranium. A slight miscalculation in dosage resulted in an immediate relocation of the company building from Texas to Pennsylvania and a stern warning from the Nuclear Regulatory Commission. Several of the test subjects are now working part-time as harbor beacons in Maine.

 


(Left) Schematic diagram of matrix. (Right) raw matrix material.


Civil rights activists have protested the release of the drug, claiming that it denies due process. Replies Jackson,"If you use the drug the way it was intended you have nothing to fear. It only explodes if you try to destroy its matrix. Well, most of the time anyway. Don't sit down too fast."

 

"It's about time we put some teeth into deterrence," said NAFB’s Gordon, "even if it's someone else's teeth."

Compassionate Medical Technologies

101 N. Broad St

Altoona, PA 17745

1-800-EXPLODE